Inoculate Yourself Against the Latest Thought Virus
What’s behind the recent stock market swoon that started September 18th? Robert Shiller, Nobel-prize winning economist, suggests it may not be any meaningful economic problem. It might be a “thought virus” comprising a global growth slowdown, deflation and secular stagnation. So what’s a thought virus and what’s the recommended treatment?
Shiller’s recent editorial in the Times, When A Stock Market Theory is Contagious talks about the stock market being driven by “popular narrative, true or not.” He calls such stories “thought viruses” and labels them pernicious and contagious. A ‘thought virus’ is an idea distinguished by its seeming common sense, endless repetition in the media, and fervent pronouncement by pundits and seers. Such is the case right now with the growth scare ‘virus’ and its nasty cousins, stagnation and deflation. After all, the ‘thought virus’ says, we have evidence, we can predict the future and all the experts agree. If only investing were that simple. Look at 2011.
Shiller goes on to describe a previous thought virus in 2011, causing the stock market to drop 22% from May to August of that year, much more than our current Fall swoon. Conventional wisdom had it that Congress would not pass a debt ceiling extension and that the US would default. Recession and other horrible things would happen. We didn’t default, but S&P downgraded our debt one notch for the first time ever. The world did not end. In fact, stocks have soared 60% since then. Great for long-term investors, fatal for market timers and short sellers, and a great example of how misleading and dangerous a thought virus can be for your portfolio.
A word from Buffett
Are we experiencing real problems now, or just growth scare, stagnation, or deflation viruses? Some experts have lined up enough evidence to make it sound real, but is it? And will stock prices fall farther based on this line of thinking? No one can know. One of Warren Buffett’s first rules is that the stock market and the economy do not move in sync, and that “just because you can tell me what the economy is doing doesn’t mean you can tell me what stock prices are.” Truer words….
What can you do?
It’s best to inoculate yourself against thought viruses so they don’t infect your investment portfolio. How is this possible? By focusing on and acting on what you can control, and ignoring what you can’t control. A professional can help you establish personalized guidelines for sorting out the signal from the noise in your investments. Basic anti-virus steps in the Osbon Capital family investment office are diversification, timeline planning, and contribution and withdrawal management. Throw in cost control, tax efficiency, consolidated reporting, and mandated no-conflict of interest rules and you are better able to sleep at night while others feel feverish over an endless loop of negative thought.
John Osbon – email@example.com
This communication may include forward-looking statements. All statements other than statements of historical fact are forward-looking statements (including words such as “believe,” “estimate,” “anticipate,” “may,” “will,” “should,” and “expect”). Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Various factors could cause actual results or performance to differ materially from those discussed in such forward-looking statements.”
“Historical performance is not indicative of future results. The investment return will fluctuate with market conditions.
Past performance is not indicative of any specific investment or future results. Views regarding the economy, securities markets or other specialized areas, like all predictors of future events, cannot be guaranteed to be accurate and may result in economic loss to the investor.
Investment strategies, philosophies, allocations and holdings are subject to change without prior notice.
This communication is intended to provide general information only and should not be construed as an offer of specifically tailored individualized advice.
While the Adviser believes the outside data sources cited to be credible, it has not independently verified the correctness of any of their inputs or calculations and, therefore, does not warranty the accuracy of any third-party sources or information.
Adviser does not endorse the statements, services or performance of any third-party vendor.
Unless stated otherwise, any mention of specific securities or investments is for hypothetical and illustrative purposes only. Adviser’s clients may or may not hold the securities discussed in their portfolios. Adviser makes no representations that any of the securities discussed have been or will be profitable.
Any IPO alerts are purely informational and should not be construed as recommendations to invest.
Adviser is not licensed to provide and does not provide legal, tax or accounting advice to clients. Advice of qualified counsel or accountant should be sought to address any specific situation requiring assistance from such licensed individuals.
Any case studies or hypothetical client profiles are for demonstration purposes only. They illustrate the breadth and depth of the many clients we represent at various life stages. Any similarities to actual Adviser’s clients past or present are strictly coincidental. Individual advice and results will vary based on each client’s circumstances, objectives and prevailing economic conditions.